"The assigned ONCO-RADS category, combined with the individual's risk (higher-risk vs general population), dictates the management pathway. The threshold for assigning ONCO-RADS categories is adapted based on the individual's risk category due to differing pre-test probabilities of cancer 4:"
"The Oncologically Relevant Findings Reporting and Data System (ONCO-RADS) 1 standardises whole-body MRI for cancer screening, addressing inconsistencies in its use, especially for individuals with cancer predisposition syndromes (e.g. Li-Fraumeni syndrome). It proposes standardised protocols, structured reporting, and a five-category assessment of oncological relevance. ONCO-RADS acknowledges the limitations and ethical considerations of MRI screening."
"The Oncologically Relevant Findings Reporting and Data System (ONCO-RADS) 1 standardises whole-body MRI for cancer screening, addressing inconsistencies in its use, especially for individuals with cancer predisposition syndromes (e.g. Li-Fraumeni syndrome). It proposes standardised protocols, structured reporting, and a five-category assessment of oncological relevance. ONCO-RADS acknowledges the limitations and ethical considerations of MRI screening."
"The specific aims of the ONCO-RADS recommendations are:"
"ONCO-RADS proposes a standard protocol primarily for individuals at higher risk, including those with cancer predisposition syndromes. While designed for higher-risk individuals, the recommendations can be adapted for use in asymptomatic individuals in the general population, with specific modifications that consider differences in cancer prevalence. A "short" protocol is proposed for cancer screening in the general population 4."
"ONCO-RADS uses a 5-tier classification system 4:"
"ONCO-RADS category 1: normal finding"
"ONCO-RADS category 2: benign finding highly likely"
"ONCO-RADS category 3: benign finding likely"
"ONCO-RADS category 4: malignant finding likely"
"ONCO-RADS category 5: malignant finding highly likely"
"The assigned ONCO-RADS category, combined with the individual's risk (higher-risk vs general population), dictates the management pathway. The threshold for assigning ONCO-RADS categories is adapted based on the individual's risk category due to differing pre-test probabilities of cancer 4:"
"The assigned ONCO-RADS category, combined with the individual's risk (higher-risk vs general population), dictates the management pathway. The threshold for assigning ONCO-RADS categories is adapted based on the individual's risk category due to differing pre-test probabilities of cancer 4:"
"low likelihood (ONCO-RADS 1-2 in general population): considered low risk of cancer; no specific follow-up required"
"intermediate likelihood (ONCO-RADS 1-2 in higher-risk or ONCO-RADS 3 in the general population): active follow-up is planned"
"intermediate likelihood (ONCO-RADS 1-2 in higher-risk or ONCO-RADS 3 in the general population): active follow-up is planned"
"high likelihood (ONCO-RADS 3-5 in higher-risk or ONCO-RADS 4-5 in the general population): further investigations, potentially with histological examination, are recommended"
"high likelihood (ONCO-RADS 3-5 in higher-risk or ONCO-RADS 4-5 in the general population): further investigations, potentially with histological examination, are recommended"
"ONCO-RADS emphasises structured reporting for whole-body MRI findings. Reports should include the indication for imaging, technique details, findings, conclusions, and management recommendations. All abnormal findings are assigned to one of seven anatomical regions (bones, head, neck, chest, abdomen, pelvis, and limbs) and given an ONCO-RADS assessment category."
"ONCO-RADS emphasises structured reporting for whole-body MRI findings. Reports should include the indication for imaging, technique details, findings, conclusions, and management recommendations. All abnormal findings are assigned to one of seven anatomical regions (bones, head, neck, chest, abdomen, pelvis, and limbs) and given an ONCO-RADS assessment category."
"RADS (Reporting and Data Systems)"
Expected headings
"Structured reporting"
"low likelihood (ONCO-RADS 1-2 in general population): considered low risk of cancer; no specific follow-up required"
"ONCO-RADS emphasises structured reporting for whole-body MRI findings. Reports should include the indication for imaging, technique details, findings, conclusions, and management recommendations. All abnormal findings are assigned to one of seven anatomical regions (bones, head, neck, chest, abdomen, pelvis, and limbs) and given an ONCO-RADS assessment category."